The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777

Sequence and organization of the human mitochondrial genome

Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,740

Aging: a theory based on free radical and radiation chemistry

Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567

The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology

Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989

Free radicals, metals and antioxidants in oxidative stress-induced cancer

Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680

Oxygen toxicity, oxygen radicals, transition metals and disease

Halliwell, B., & Gutteridge, J. M. C. (1984) · Biochemical Journal · doi:10.1042/bj2190001 · Cited by 5,330

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227

Mitochondrial formation of reactive oxygen species

Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084

Signaling to NF-κB

Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842

Molecular chaperones in cellular protein folding

Hartl, F. U. (1996) · Nature · doi:10.1038/381571a0 · Cited by 3,584

AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY

FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990

Reactive oxygen species in cell signaling

Thannickal, V. J., & Fanburg, B. L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.6.l1005 · Cited by 2,950

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Premature ageing in mice expressing defective mitochondrial DNA polymerase

Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.

Nordberg, J., & Arnér, E. S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00724-9 · Cited by 2,720

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165

Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts

Halliwell, B., & Gutteridge, J. M. C. (1986) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(86)90305-x · Cited by 2,038

Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy

Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×

The Biologic Clock: The Mitochondria?

Harman, D. (1972) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1972.tb00787.x · Cited by 2,019

The action potential in mammalian central neurons

Bean, B. P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2148 · Cited by 1,785

Extension of murine life span by overexpression of catalase targeted to mitochondria

Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region

Moi, P., Chan, K., Asunis, I., Cao, A., & Kan, Y. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9926 · Cited by 1,607

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570

Rate of depurination of native deoxyribonucleic acid

Lindahl, T. L., & Nyberg, B. (1972) · Biochemistry · doi:10.1021/bi00769a018 · Cited by 1,558

Microglia in neurodegenerative disease

Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543

Association between Early-Onset Parkinson's Disease and Mutations in theParkinGene

Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J. R., Michele, G. D., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,489

α-Synuclein Is Degraded by Both Autophagy and the Proteasome

Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429

Oxidant signals and oxidative stress

Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393

Age-related changes in oxidized proteins.

Oliver, C. N., Ahn, B. W., Moerman, E. J., Goldstein, S., & Stadtman, E. R. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45598-6 · Cited by 1,306

MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE

Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,304

Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein

Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266

Microdomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences

Rizzuto, R., & Pozzan, T. (2005) · Physiological Reviews · doi:10.1152/physrev.00004.2005 · Cited by 1,201

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161

Glutathione dysregulation and the etiology and progression of human diseases

Ballatori, N., Krance, S. M., Notenboom, S., Shi, S., Tieu, K., & Hammond, C. L. (2009) · Biological Chemistry · doi:10.1515/bc.2009.033 · Cited by 1,145

Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127

Trends in oxidative aging theories

Muller, F. L., Lustgarten, M. S., Jang, Y., Richardson, A., & Van Remmen, H. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.034 · Cited by 1,053

Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins

Brand, M. D., Affourtit, C., Esteves, T. C., Green, K., Lambert, A. J., Miwa, S., Pakay, J. L., & Parker, N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.034 · Cited by 1,032

Biological Tyrosine Nitration: A Pathophysiological Function of Nitric Oxide and Reactive Oxygen Species

Ischiropoulos, H. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0755 · Cited by 1,025

Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice

Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995

Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases

Linnane, A., Ozawa, T., Marzuki, S., & Tanaka, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92145-4 · Cited by 983

‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

Chan, C. S., Guzmán, J. N., Ilijić, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 936

Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons

Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 896

Astrocytes and Brain Injury

Chen, Y., & Swanson, R. A. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000044631.80210.3c · Cited by 895

Reactive oxygen species and cell signaling: Respiratory burst in macrophage signaling

Forman, H. J., & Torres, M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2206007 · Cited by 891

Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons

Parkes, T. L., Elia, A., Dickinson, D., Hilliker, A. J., Phillips, J. P., & Boulianne, G. L. (1998) · Nature Genetics · doi:10.1038/534 · Cited by 862

Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients

Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855

Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease.

de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833

Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

Lee, M. K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. S., Dawson, T. M., Copeland, N. G., Jenkins, N. A., & Price, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132197599 · Cited by 824

Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system

Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813

Parkinson’s disease: genetics and pathogenesis

Shulman, J. M., De Jager, P. L., & Feany, M. B. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130242 · Cited by 801

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791

Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid

Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 774

Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease

Xu, J., Kao, S., Lee, F. J. S., Song, W., Jin, L., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 768

Does oxidative damage to DNA increase with age?

Hamilton, M. L., Van Remmen, H., Drake, J. A., Yang, H., Guo, Z. M., Kewitt, K., Walter, C. A., & Richardson, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171202698 · Cited by 768

Expression of Nrf2 in Neurodegenerative Diseases

Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760

Oxidative stress and nitration in neurodegeneration: Cause, effect, or association?

Ischiropoulos, H., & Beckman, J. S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317638 · Cited by 759

Parkinson's disease

Thomas, B., & Beal, M. F. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm159 · Cited by 748

Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons

Verkhratsky, A. (2004) · Physiological Reviews · doi:10.1152/physrev.00004.2004 · Cited by 718

Redox signaling: hydrogen peroxide as intracellular messenger

Rhee, S. G. (1999) · Experimental & Molecular Medicine · doi:10.1038/emm.1999.9 · Cited by 701

Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation–reduction state

Kushnareva, Y., Murphy, A. N., & Andreyev, A. Y. (2002) · Biochemical Journal · doi:10.1042/bj20021121 · Cited by 696

Microglia derived from aging mice exhibit an altered inflammatory profile

Sierra, A., Gottfried‐Blackmore, A. C., McEwen, B. S., & Bulloch, K. (2007) · Glia · doi:10.1002/glia.20468 · Cited by 688

Para-Inflammation in the Aging Retina

Xu, H., Chen, M., & Forrester, J. V. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.06.001 · Cited by 659 · cited 1×

Production of superoxide anions by a CNS macrophage, the microglia

Colton, C. A., & Gilbert, D. L. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)80305-8 · Cited by 614

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

Sofic, E., Lange, K. W., Jellinger, K. A., & Riederer, P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90355-b · Cited by 591

A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease

Alam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P. G., & Halliwell, B. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547

Increase in Single L-Type Calcium Channels in Hippocampal Neurons During Aging

Thibault, O., & Landfield, P. W. (1996) · Science · doi:10.1126/science.272.5264.1017 · Cited by 513

Age-related alterations in the dynamic behavior of microglia

Damani, M. R., Zhao, L., Fontainhas, A. M., Amaral, J., Fariss, R. N., & Wong, W. T. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2010.00660.x · Cited by 504

Molecular chaperones in cellular protein folding

Martin, J., & Hartl, F. U. (1994) · BioEssays · doi:10.1002/bies.950160916 · Cited by 498

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

Zecca, L., Stroppolo, A., Gatti, A., Tampellini, D., Toscani, M., Gallorini, M., Giaveri, G., Arosio, P., Santambrogio, P., Fariello, R. G., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403495101 · Cited by 495

Parkin-deficient mice are not a robust model of parkinsonism

Perez, F. A., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409598102 · Cited by 477

Role of oxidative stress and protein oxidation in the aging process1,2 1Guest Editor: Earl Stadtman 2This article is part of a series of reviews on “Oxidatively Modified Proteins in Aging and Disease.” The full list of papers may be found on the homepage of the journal.

Sohal, R. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00856-0 · Cited by 477

Protein Kinase C ß and Prolyl Isomerase 1 Regulate Mitochondrial Effects of the Life-Span Determinant p66 Shc

Pinton, P., Rimessi, A., Marchi, S., Orsini, F., Migliaccio, E., Giorgio, M., Contursi, C., Minucci, S., Mantovani, F., Wieckowski, M. R., et al. (2007) · Science · doi:10.1126/science.1135380 · Cited by 474

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472

AETIOLOGY OF PARKINSON'S DISEASE

Calne, D., & Langston, J. W. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90802-4 · Cited by 469

High-quality life extension by the enzyme peptide methionine sulfoxide reductase

Ruan, H., Tang, X. D., Chen, M.-L., Joiner, M.-L. A., Sun, G., Brot, N., Weissbach, H., Heinemann, S. H., Iverson, L., Wu, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032671199 · Cited by 454

A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra

Saggu, H. K., Cooksey, J., Dexter, D. T., Wells, F. R., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb11759.x · Cited by 454

Clearance of α-Synuclein Oligomeric Intermediates via the Lysosomal Degradation Pathway

Lee, H.-J., Khoshaghideh, F., Patel, S., & Lee, S.-J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3809-03.2004 · Cited by 445

Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro

Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?

Chu, Y., & Kordower, J. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.021 · Cited by 423

Elevated 4-Hydroxynonenal in Ventricular Fluid in Alzheimer’s Disease

Lovell, M. A., Ehmann, W. D., Mattson, M. P., & Markesbery, W. R. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00108-5 · Cited by 415

Mitochondrial point mutations do not limit the natural lifespan of mice

Vermulst, M., Bielas, J. H., Kujoth, G. C., Ladiges, W. C., Rabinovitch, P. S., Prolla, T. A., & Loeb, L. A. (2007) · Nature Genetics · doi:10.1038/ng1988 · Cited by 404

Protein oxidation and proteolysis during aging and oxidative stress

Starke-Reed, P. E., & Oliver, C. N. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90402-5 · Cited by 398

Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration

Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Monte, D. A. D., Emson, P. C., & Miller, G. W. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 389

PARK7, a Novel Locus for Autosomal Recessive Early-Onset Parkinsonism, on Chromosome 1p36

van Duijn, C. M., Dekker, M. C. J., Bonifati, V., Galjaard, R. H., Houwing‐Duistermaat, J. J., Snijders, P. J. L. M., Testers, L., Breedveld, G. J., Horstink, M. W. I. M., Sandkuijl, L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/322996 · Cited by 385

Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases.

Biemond, P., van Eijk, H. G., Swaak, A. J., & Koster, J. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111364 · Cited by 380

Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase.

Huang, C. S., Chang, L., Anderson, M. E., & Meister, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36569-x · Cited by 374

DRUG TREATMENT IN PSYCHIATRY

PETERS, L. L. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90527-6 · Cited by 372

Iron Toxicity in Diseases of Aging: Alzheimer's Disease, Parkinson's Disease and Atherosclerosis

Altamura, S., & Muckenthaler, M. U. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1010 · Cited by 369

Parkinson's disease

MARSDEN, C. D. (1990) · The Lancet · doi:10.1016/0140-6736(90)91006-v · Cited by 366

Clinical and genetic delineation of neurodegeneration with brain iron accumulation

Gregory, A., Polster, B. J., & Hayflick, S. J. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061929 · Cited by 364

Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects

Borghi, R., Marchese, R., Negro, A., Marinelli, L., Forloni, G., Zaccheo, D., Abbruzzese, G., & Tabaton, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01153-8 · Cited by 363

Misfolded proteinase K–resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies

Neumann, M., Kahle, P. J., Giasson, B. I., Ozmen, L., Borroni, E., Spooren, W. P. J. M., Müller, V., Odoy, S., Fujiwara, H., Hasegawa, M., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15777 · Cited by 363

Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2002) · The FASEB Journal · doi:10.1096/fj.02-0216fje · Cited by 362

Incidence of parkinsonism and Parkinson disease in a general population

de Lau, L. M. L., Giesbergen, P. C. L. M., de Rijk, M. C., Albert Hofman, D., Koudstaal, P. J., & Breteler, M. M. B. (2004) · Neurology · doi:10.1212/01.wnl.0000140706.52798.be · Cited by 360

Accumulation of Phosphorylated α-Synuclein in Aging Human Brain

Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 354

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice

Gu, X., Long, C.-X., Sun, L., Xie, C., Lin, X. Z., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 351

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

Pearce, R. K. B., Owen, A., Daniel, S. E., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350

Nrf2 Controls Constitutive and Inducible Expression of ARE-driven Genes through a Dynamic Pathway Involving Nucleocytoplasmic Shuttling by Keap1

Nguyen, T., Sherratt, P. J., Nioi, P., Yang, C. S., & Pickett, C. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503074200 · Cited by 345

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration

Bartzokis, G., Tishler, T. A., Lu, P. H., Villablanca, P. J., Altshuler, L. L., Carter, M., Huang, D., Edwards, N. J., & Mintz, J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.005 · Cited by 343

Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo

Dehmer, T., Lindenau, J. H., Haid, S., DICHGANS, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337

Midbrain Dopaminergic Cell Loss in Parkinson's Disease and MPTP‐Induced Parkinsonism: Sparing of Calbindin‐D25k—Containing Cellsa

German, D. C., Manaye, K. F., Sonsalla, P. K., & Brooks, B. A. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24523.x · Cited by 319

Roles of Subthreshold Calcium Current and Sodium Current in Spontaneous Firing of Mouse Midbrain Dopamine Neurons

Puopolo, M., Raviola, E., & Bean, B. P. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4341-06.2007 · Cited by 319

Differential compartmentalization of brain ascorbate and glutathione between neurons and glia

Rice, M. E., & Russo-Menna, I. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00347-3 · Cited by 313

Formation of 8-hydroxy(deoxy)guanosine and generation of strand breaks at guanine residues in DNA by singlet oxygen

Devasagayam, T. P. A., Steenken, S., Obendorf, M. S. W., Schulz, W. A., & Sies, H. (1991) · Biochemistry · doi:10.1021/bi00239a029 · Cited by 304

How much phenotypic variation can be attributed to parkin genotype?

Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., Michele, G. D., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 304

Parkin mutations are frequent in patients with isolated early‐onset parkinsonism

Periquet, M., Latouche, M., Lohmann, E., Rawal, N., Michele, G. D., Ricard, S., Teive, H. A. G., Fraix, V., Vidailhet, M., Nicholl, D. J., et al. (2003) · Brain · doi:10.1093/brain/awg136 · Cited by 296

Age-related Iron Deposition in the Basal Ganglia: Quantitative Analysis in Healthy Subjects

Aquino, D., Bizzi, A., Grisoli, M., Garavaglia, B., Bruzzone, M. G., Nardocci, N., Savoiardo, M., & Chiapparini, L. (2009) · Radiology · doi:10.1148/radiol.2522081399 · Cited by 296

Misfolded proteinase K–resistant hyperphosphorylated α-synuclein in aged transgenic mice with locomotor deterioration and in human α-synucleinopathies

Neumann, M., Kahle, P. J., Giasson, B. I., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215777 · Cited by 291

Intraneuronal dopamine-quinone synthesis: a review

Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284

Age-related changes in glutathione and glutathione-related enzymes in rat brain

Zhu, Y., Carvey, P. M., & Ling, Z. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.063 · Cited by 279

Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease

Kish, S. J., Shannak, K. S., Rajput, A. H., Deck, J. H. N., & Hornykiewicz, O. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09766.x · Cited by 272

Hydroxyl radical attack on dopamine.

Slivka, A., & Cohen, G. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36277-4 · Cited by 264

Dopamine transporters decrease with age.

Volkow, N. D., Ding, Y., Fowler, J. S., Wang, G., Logan, J., Gatley, S. J., Hitzemann, R., Smith, G., Fields, S. D., & Gur, R. C. (1996) · PubMed · Cited by 262

Human α-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine

Junn, E., & Mouradian, M. M. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00016-2 · Cited by 262

Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals

Chen, C., Pung, D., Leong, V., Hebbar, V., Shen, G., Nair, S., Li, W., & Kong, A.-N. T. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.021 · Cited by 260

Lewy body-related ?-synucleinopathy in the aged human brain

Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 253

Age-Related Activation of Microglia and Astrocytes: In Vitro Studies Show Persistent Phenotypes of Aging, Increased Proliferation, and Resistance to Down-Regulation

Rozovsky, I., Finch, C. E., & Morgan, T. E. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00169-3 · Cited by 252

GSK‐3β down‐regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress

Rojo, A. I., de Sagarra, M. R., & Cuadrado, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05124.x · Cited by 246

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

Shachar, D. B., Kahana, N., Kampel, V., Warshawsky, A., & Youdim, M. B. H. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.09.005 · Cited by 246

Early‐onset familial parkinsonism due to POLG mutations

Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., & DiMauro, S. (2006) · Annals of Neurology · doi:10.1002/ana.20831 · Cited by 239

Amino acid sequence and function of the light subunit of rat kidney gamma-glutamylcysteine synthetase.

Huang, C. S., Anderson, M. E., & Meister, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80764-9 · Cited by 237

Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-κB

Helenius, M., Hänninen, M., Lehtinen, S. K., & Salminen, A. (1996) · Biochemical Journal · doi:10.1042/bj3180603 · Cited by 233

Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging

Meulener, M. C., Xu, K., Thomson, L., Ischiropoulos, H., & Bonini, N. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601891103 · Cited by 230

Heat-induced depyrimidination of deoxyribonucleic acid in neutral solution

Lindahl, T. L., & Karlström, O. H. (1973) · Biochemistry · doi:10.1021/bi00749a020 · Cited by 229

The role of calcium regulation in brain aging: reexamination of a hypothesis

Khachaturian, Z. S. (1989) · Aging Clinical and Experimental Research · doi:10.1007/bf03323872 · Cited by 224

Distribution, type, and origin of Parkin mutations: Review and case studies

Hedrich, K., Eskelson, C., Wilmot, B., Marder, K. S., Harris, J. M., Garrels, J., Meija‐Santana, H., Vieregge, P., Jacobs, H., Bressman, S., et al. (2004) · Movement Disorders · doi:10.1002/mds.20234 · Cited by 224

Redox imbalance

Berg, D., Youdim, M. B. H., & Riederer, P. F. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0976-5 · Cited by 221

Nigral pathology and parkinsonian signs in elders without Parkinson disease

Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2011) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 220

Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease

Foroud, T., Uniacke, S. K., Liu, L., Pankratz, N., Rudolph, A., Halter, C. A., Shults, C. W., Marder, K. S., Conneally, P. M., Nichols, W. C., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000049470.00180.07 · Cited by 215

Possible role of neuromelanin in the pathogenesis of Parkinson's disease

Mann, D. M. A., & Yates, P. O. (1983) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(83)90074-x · Cited by 211

LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASE

Dexter, D. T., Carter, C. J., Javoy-Agid, F., Agid, Y., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92471-2 · Cited by 207

Reactive Oxygen and Nitrogen Species: Weapons of Neuronal Destruction in Models of Parkinson's Disease

Przedborski, S., & Ischiropoulos, H. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.685 · Cited by 202

Therapeutic approaches to inflammation in neurodegenerative disease

Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 189

Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation

Li, W., Lesuisse, C., Xu, Y., Troncoso, J. C., Price, D. L., & Lee, M. K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1370-04.2004 · Cited by 185

Differential expressions of antioxidant status in aging rats: the role of transcriptional factor Nrf2 and MAPK signaling pathway

Shih, P., & Yen, G. (2006) · Biogerontology · doi:10.1007/s10522-006-9033-y · Cited by 185

α-synuclein implicated in Parkinson’s disease catalyses the formation of hydrogen peroxide in vitro

Turnbull, S., Tabner, B. J., El‐Agnaf, O. M. A., Moore, S., Davies, Y., & Allsop, D. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00513-5 · Cited by 183

Epidemiologic observations on Parkinson's disease

Morens, D. M., Davis, J. W., Grandinetti, A., Ross, G. W., Popper, J. S., & White, L. R. (1996) · Neurology · doi:10.1212/wnl.46.4.1044 · Cited by 183

Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease

Dei, R., Takeda, A., Niwa, H., Li, M., Nakagomi, Y., Watanabe, M., Inagaki, T., Washimi, Y., Yasuda, Y., Horie, K., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0523-y · Cited by 179

Dopamine and Serotonin Systems in Human and Rodent Brain: Effects of Age and Neurodegenerative Disease

Morgan, D., May, P. C., & Finch, C. E. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb04641.x · Cited by 177

Iron, Transferrin, and Ferritin in the Rat Brain During Development and Aging

Roskams, A. J., & Connor, J. R. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020709.x · Cited by 173

Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?

Gegg, M. E., Beltrán, B., Salas-Pino, S., Bolaños, J. P., Clark, J. B., Moncada, S., & Heales, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01821.x · Cited by 168

CLINICAL RELEVANCE OF SPECIFIC IgG ANTIBODIES TO CARDIOLIPIN

Faux, J. A., Byron, M., & Chapel, H. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92069-2 · Cited by 166

Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function

Periquet, M., Corti, O., Jacquier, S., & Brice, A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03442.x · Cited by 164

Effect of hydrogen peroxide on calcium homeostasis in smooth muscle cells

Roveri, A., Coassin, M., Maiorino, M., Zamburlini, A., van Amsterdam, F. T. M., Ratti, E., & Ursini, F. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90671-i · Cited by 162

Monoamine oxidase, brain ageing and degenerative diseases

Benedetti, M. S., & Dostert, P. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90198-6 · Cited by 161

Desferrioxamine and vitamin E protect against iron and MPTP-induced neurodegeneration in mice

Lan, J., & Jiang, D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01277665 · Cited by 160

The concentration of glial fibrillary acidic protein increases with age in the mouse and rat brain

O'Callaghan, J. P., & Miller, D. B. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90057-q · Cited by 152

The effects of exogenous antioxidants on lifespan and oxidative stress resistance in Drosophila melanogaster

Magwere, T., West, M. J., Riyahi, K., Murphy, M. P., Smith, R. A. J., & Partridge, L. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.12.009 · Cited by 150

Influence of Heterozygosity for Parkin Mutation on Onset Age in Familial Parkinson Disease

Sun, M., Latourelle, J. C., Wooten, G. F., Lew, M., Klein, C., Shill, H. A., Golbe, L. I., Mark, M. H., Racette, B. A., Perlmutter, J. S., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.6.826 · Cited by 146

Age‐related changes in the human nigrostriatal dopaminergic system

Keyser, J. D., Ebinger, G., & Vauquelin, G. (1990) · Annals of Neurology · doi:10.1002/ana.410270210 · Cited by 146

In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age

Fornstedt, B., Pileblad, E., & Carlsson, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04183.x · Cited by 143

Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases

Roy, A., Jana, A., Yatish, K., Freidt, M. B., Fung, Y. K., Martinson, J., & Pahan, K. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.026 · Cited by 139

Age-related changes in the regulation of transcription factor NF-κB in rat brain

Korhonen, P., Helenius, M., & Salminen, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00190-0 · Cited by 138 · cited 2×

Role of Mendelian genes in “sporadic” Parkinson's disease

Lesage, S., & Brice, A. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70022-0 · Cited by 135

Loss in oxidative stress tolerance with aging linked to reduced extracellular signal‐regulated kinase and Akt kinase activities

Ikeyama, S., Kokkonen, G. C., Shack, S., Wang, X., & Holbrook, N. J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0409fje · Cited by 134

Could a loss of α‐synuclein function put dopaminergic neurons at risk?

Perez, R. G., & Hastings, T. G. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02423.x · Cited by 133

parkin counteracts symptoms in a Drosophila model of Parkinson's disease

Haywood, A. F. M., & Staveley, B. E. (2004) · BMC Neuroscience · doi:10.1186/1471-2202-5-14 · Cited by 129

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease

von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 128

Mitochondrial iron accumulation with age and functional consequences

Seo, A. Y., Xu, J., Servais, S., Hofer, T., Marzetti, E., Wohlgemuth, S. E., Knutson, M. D., Chung, H. Y., & Leeuwenburgh, C. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00418.x · Cited by 127

Aging and the nigrostriatal dopamine system: a non-human primate study.

Irwin, I., DeLanney, L. E., McNeill, T. H., Chan, P., Forno, L. S., Murphy, G. M., Monte, D. A. D., Sandy, M. S., & Jw, L. (1994) · PubMed · Cited by 125

Increasing striatal iron content associated with normal aging

Martin, W. R. W., Ye, F. Q., & Allen, P. S. (1998) · Movement Disorders · doi:10.1002/mds.870130214 · Cited by 122

Analysis of gial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease

Porchet, R., Probst, A., Bouras, C., Dráberová, E., Dráber, P., & Riederer, B. M. (2003) · PROTEOMICS · doi:10.1002/pmic.200300456 · Cited by 121

Modifications of the iron–neuromelanin system in Parkinson's disease

Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117

Highly Potent and Specific GSK‐3β Inhibitors That Block Tau Phosphorylation and Decrease α‐Synuclein Protein Expression in a Cellular Model of Parkinson's Disease

Kozikowski, A. P., Gaisina, I. N., Petukhov, P. A., Sridhar, J., King, L. T., Blond, S. Y., Duka, T., Rusnak, M., & Sidhu, A. (2006) · ChemMedChem · doi:10.1002/cmdc.200500039 · Cited by 106

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits

Beach, T. G., Sue, L. I., Walker, D. G., Lue, L. F., Connor, D. J., Caviness, J. N., Sabbagh, M. N., & Adler, C. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0250-5 · Cited by 104

Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease

Beal, M. F. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70812-0 · Cited by 104

Detection of Superoxide Production by Activated Microglia Using a Sensitive and Specific Chemiluminescence Assay and Microglia‐Mediated PC12h Cell Death

Tanaka, M., Sotomatsu, A., Yoshida, T., Hirai, S., & Nishida, A. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63010266.x · Cited by 103

Glial reaction in aging and Alzheimer's disease

Unger, J. W. (1998) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(19981001)43:1 · Cited by 103

Dopamine Biosynthesis Is Regulated byS-Glutathionylation

Borges, C. R., Geddes, T. J., Watson, J. T., & Kuhn, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209042200 · Cited by 102

Functional properties of dopaminergic neurones in the mouse olfactory bulb

Pignatelli, A., Kobayashi, K., Okano, H., & Belluzzi, O. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.084632 · Cited by 99

Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons

González‐Hernández, T., Barroso‐Chinea, P., Cruz‐Muros, I., Pérez-Delgado, M. D. M., & Rodrı́guez, M. (2004) · The Journal of Comparative Neurology · doi:10.1002/cne.20323 · Cited by 96

The awakening of α-synuclein

Goedert, M. (1997) · Nature · doi:10.1038/40767 · Cited by 95

Age-Associated Changes of Superoxide Dismutase and Catalase Activities in the Rat Brain

Tsay, H.-J., Wang, P., Wang, S.-L., & Ku, H. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253362 · Cited by 90

Mixed lineage kinase–c‐jun N‐terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease

Silva, R. M., Kuan, C.-Y., RAKIC, P. T., & Burke, R. E. (2005) · Movement Disorders · doi:10.1002/mds.20390 · Cited by 88

Genetic mutations and functions of PINK1

Kawajiri, S., Saiki, S., Sato, S., & Hattori, N. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.001 · Cited by 87

L-Type Calcium Channels Mediate a Slow Excitatory Synaptic Transmission in Rat Midbrain Dopaminergic Neurons

Bonci, A., Grillner, P., Mercuri, N. B., & Bernardi, G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06693.1998 · Cited by 85

St. Martin's

Creeley, R. (1971) · Cited by 84

Pink1 suppresses α-synuclein-induced phenotypes in a Drosophila model of Parkinson’s disease

Todd, A. M., & Staveley, B. E. (2008) · Genome · doi:10.1139/g08-085 · Cited by 83

Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia.

Dexter, D. T., Sian, J., Jenner, P. G., & MARSDEN, C. D. (1993) · PubMed · Cited by 82

Mechanisms of hydrogen peroxide-induced calcium dysregulation in PC12 cells

Wang, H., & Joseph, J. A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00241-0 · Cited by 81

α-Synuclein and Dopamine Metabolism

Yu, S., Uéda, K., & Chan, P. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:243 · Cited by 77

Inhibitors of Mitochondrial Respiration, Iron (II), and Hydroxyl Radical Evoke Release and Extracellular Hydrolysis of Glutathione in Rat Striatum and Substantia Nigra

Han, J., Cheng, F., Yang, Z., & Dryhurst, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.731683.x · Cited by 74

Age-associated changes in SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid

Hsieh, C.-C., Rosenblatt, J. I., & Papaconstantinou, J. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00083-6 · Cited by 74

Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice

Yamaguchi, H., & Shen, J. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-10 · Cited by 74

Oxidative inactivation of tyrosine hydroxylase in substantia nigra of aged rat

Delacruz, C., Revilla, E., Venero, J. L., Ayala, A., Cano, J., & MacHado, A. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02025-x · Cited by 72

Gene–Environment Interactions in Parkinson's Disease: The Importance of Animal Modeling

Horowitz, M. P., & Greenamyre, J. T. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.138 · Cited by 72

Effects of Aging on Neuroprotective and Neurotoxic Properties of Microglia in Neurodegenerative Diseases

Sawada, M., Sawada, H., & Nagatsu, T. (2008) · Neurodegenerative Diseases · doi:10.1159/000113717 · Cited by 71

Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents

Agrawal, R., Sharma, P. K., & Rao, G. S. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00412-7 · Cited by 70

Substantia Nigra Marinesco Bodies Are Associated with Decreased Striatal Expression of Dopaminergic Markers

Beach, T. G., Walker, D. G., Sue, L. I., Newell, A., Adler, C., & Joyce, J. N. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.329 · Cited by 66

Mitochondrial kinases in Parkinson’s disease: Converging insights from neurotoxin and genetic models

Dagda, R. K., Zhu, J., & Chu, C. T. (2009) · Mitochondrion · doi:10.1016/j.mito.2009.06.001 · Cited by 64

Aggregation of α-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system

Kim, K. S., Choi, S. Y., Kwon, H. Y., Won, M. H., Kang, T., & Kang, J. H. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00741-4 · Cited by 60

Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls

Mann, J. J., & Stanley, M. (1984) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1984.tb02477.x · Cited by 59

Neuroglia

(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195152227.001.0001 · Cited by 59

Apoptosis‐inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins

Perier, C., Bové, J., Dehay, B., Jackson-Lewis, V. R., Rabinovitch, P. S., Przedborski, S., & Vila, M. (2010) · Annals of Neurology · doi:10.1002/ana.22034 · Cited by 58

Quantitative localization of human brain monoamine oxidase B by large section autoradiography using l-[3H]deprenyl

Jossan, S. S., Gillberg, P., d'Argy, R., Aquilonius, S., Låangstro¨m, B., Halldin, C., & Oreland, L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90575-g · Cited by 55

Effect of Thioacetamide on the Hepatic Expression of γ-Glutamylcysteine Synthetase Subunits in the Rat

Lu, S. C.-L., Huang, Z., Yang, H., & Tsukamoto, H. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8729 · Cited by 53

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications

Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683

Oxidative stress, mitochondrial damage and neurodegenerative diseases.

Guo, C., Sun, L., Chen, X., & Zhang, D. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.21.009 · Cited by 1,367

Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury

Farina, M., Ávila, D. S., da Rocha, J. B. T., & Aschner, M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.006 · Cited by 577

Physicochemical Properties of Cells and Their Effects on Intrinsically Disordered Proteins (IDPs)

Theillet, F., Binolfi, A., Frembgen-Kesner, T., Hingorani, K. S., Sarkar, M., Kyne, C., Li, C., Crowley, P. B., Gierasch, L. M., Pielak, G. J., et al. (2014) · Chemical Reviews · doi:10.1021/cr400695p · Cited by 521

The Role of Dopamine and Its Dysfunction as a Consequence of Oxidative Stress

Olguı́n, H. J., Guzmán, D. C., García, E. H., & Mejía, G. B. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9730467 · Cited by 514

www.mdpi.com/journal/ijms The Role of Free Radicals in the Aging Brain and Parkinson’s Disease: Convergence and Parallelism

Kumar, H., Lim, H.-W., More, E. V., Kim, B.-W., Kim, I. S., & Choi, D.-K. (2012)

Free radicals in Parkinson's disease

Koutsilieri, E., Scheller, C., Grünblatt, E., Keinosuke, N. A. R. A., Li, J., & Riederer, P. F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1201-7 · Cited by 117

Free Radicals and Parkinson's Disease

Sood, P., Mohan, M., Kaur, G., Rani, L., Kanojia, N., & Thapa, K. (2025) · Apple Academic Press eBooks · doi:10.1201/9781003560579-13

Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease

Venkateshappa, C., Harish, G., Mythri, R. B., Mahadevan, A., Bharath, M. M. S., & Shankar, S. K. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0619-7 · Cited by 177

Culprit effect of oxidative stress in the development of Parkinson's disease: A conundrum of senescence

Saxena, R., & Rai, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818698-5.00005-5